Sleeping too much or too little could increase your risk of an incurable lung disease: Study
| Updated: Jan 2, 2020, 14:33 IST
A new study warns sleeping for too long or for insufficient amounts can increase your risk of a lung disease that is incurable. Snoozing for 11 hours or for only four hours can significantly increase your risk of pulmonary fibrosis. Experts say you should be getting at least seven hours of sleep. The study's findings were originally published in the journal Proceedings of the National Academy of Sciences.
This disease kills thousands of people across the globe. Targeting the body clock helps to reduce fibrosis in vitro. This could help researchers develop better treatment options.
“Pulmonary fibrosis is a devastating condition which is incurable at present. Therefore, the discovery that the body clock is potentially a key player potentially opens new ways to treat or prevent the condition,” study lead author John Blaikley from The University of Manchester in the UK, told a news portal. Adding, "More work need to be done around studying the association between pulmonary fibrosis and sleep duration to establish both causation and reproducibility."
A Yale University study explains learning about how idiopathic pulmonary fibrosis (IPF) progresses in the lungs can help scientists come up with a treatment for the disease. 50 per cent of patients with IPF will reportedly die within five years after being diagnosed with the medical condition. The cause of the condition is unknown. FDA-approved drugs used to treat IPFcan slow down the disease's progress. However, it cannot reverse it.
"The drugs may not be pleasant, but they work," Naftali Kaminski, M.D., the Boehringer-Ingelheim Endowed Professor of Internal Medicine and chief of the Section of Pulmonary, Critical Care, and Sleep Medicine at Yale School of Medicine, told a news portal. Adding, "There's hope on the horizon."
Kaminski further explained: "My group has felt for years that to develop interventions for IPF that are more effective, we need to understand how the disease progresses in the human lung." Adding, "This is the first evidence that different stages of the disease may require different interventions."
Picture Courtesy: Google Images
This disease kills thousands of people across the globe. Targeting the body clock helps to reduce fibrosis in vitro. This could help researchers develop better treatment options.
“Pulmonary fibrosis is a devastating condition which is incurable at present. Therefore, the discovery that the body clock is potentially a key player potentially opens new ways to treat or prevent the condition,” study lead author John Blaikley from The University of Manchester in the UK, told a news portal. Adding, "More work need to be done around studying the association between pulmonary fibrosis and sleep duration to establish both causation and reproducibility."
A Yale University study explains learning about how idiopathic pulmonary fibrosis (IPF) progresses in the lungs can help scientists come up with a treatment for the disease. 50 per cent of patients with IPF will reportedly die within five years after being diagnosed with the medical condition. The cause of the condition is unknown. FDA-approved drugs used to treat IPFcan slow down the disease's progress. However, it cannot reverse it.
"The drugs may not be pleasant, but they work," Naftali Kaminski, M.D., the Boehringer-Ingelheim Endowed Professor of Internal Medicine and chief of the Section of Pulmonary, Critical Care, and Sleep Medicine at Yale School of Medicine, told a news portal. Adding, "There's hope on the horizon."
Kaminski further explained: "My group has felt for years that to develop interventions for IPF that are more effective, we need to understand how the disease progresses in the human lung." Adding, "This is the first evidence that different stages of the disease may require different interventions."
Picture Courtesy: Google Images